Metalloprotease activation of myostatin, and methods of modulating myostatin activity
It has been determined that metalloprotease cleavage of a myostatin pro peptide results in activation of a latent inactive myostatin to an active form. Accordingly, methods of identifying agents that modulate metalloprotease mediated activation of myostatin are provided, as are agents identified using such methods. Also provided are methods of modulating muscle growth in an organism by increasing or decreasing metalloprotease mediated cleavage of a myostatin pro peptide.
1. A method of modulating myostatin activation, comprising contacting a latent myostatin complex comprising a myostatin pro-peptide and a myostatin C-terminal fragment, and a metalloprotease that can cleave the myostatin pro-peptide, wherein the metalloprotease is mammalian bone morphogenic protein-1 (BMP-1), with an agent that increases or decreases proteolytic cleavage of the pro-peptide by the metalloprotease, wherein the myostatin complex comprises SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: wherein the agent is a peptide consisting of SEQ ID NO: 9-23, thereby modulating myostatin activation.
2. The method of claim 1 , wherein said contacting is performed on a sample in vitro.
3. The method of claim 2 , wherein the sample comprises a cell sample, a tissue sample, or a biological fluid sample.
4. The method of claim 1 , wherein said contacting is performed in vivo, said method comprising administering the agent to a mammalian subject.
5. The method of claim 4 , wherein the agent decreases proteolytic cleavage of the pro-peptide by the metalloprotease, thereby reducing or inhibiting myostatin activation.
6. The method of claim 5 , wherein, in the subject, muscle mass is increased, fat content is decreased, or a combination thereof.
7. The method of claim 6 , wherein the mammalian subject is an animal raised as a food source.
8. The method of claim 4 , wherein the mammalian subject is an ovine species, a porcine species, or a bovine species.
9. The method of claim 4 , wherein the mammalian subject is a human subject.